<DOC>
	<DOCNO>NCT02065492</DOCNO>
	<brief_summary>Children thalassemia may high iron level receive blood transfusion . These high iron level damage effect body , especially heart . Conventionally chelation therapy give prevention iron buildup heart . However , current research show another drug , amlodipine , also help slow deposition iron heart . This study design see patient receive amlodipine along regular chelation therapy slow rate iron buildup heart compare patient receive chelation .</brief_summary>
	<brief_title>Amlodipine Myocardial Iron Thalassemia</brief_title>
	<detailed_description>Null Hypothesis There difference efficacy chelation plus amlodipine therapy chelation therapy alone retard rate myocardial iron deposition thalassemia patient iron overload constant transfusion need . Alternate Hypothesis Chelation plus amlodipine therapy efficacious chelation therapy alone retard rate myocardial iron deposition thalassemia patient iron overload constant transfusion need . The aim investigator study determine amlodipine , L-type specific calcium channel blocker , addition standard aggressive chelation therapy , retard deposition iron myocardium thalassemia patient significant myocardial iron load without cardiomyopathy .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Pediatric patient age ≥ 6 ≤ 20 year manage AKUH least 1 year ≥ 10 blood transfusion life time Transfusion need ≥ 180 ml/kg/year Serum ferritin ≥ 1000 ug/dl Patient deem capable receive chelation therapy ( treat hematologist ) either subcutaneous infusion Deferoxamine ( Desferal ) ( 35 day week ) oral deferasirox ( daily ) Defeperione ( oral ) combination Desferal Defeperione . Patients stable chelation regimen ≥ 6 month Completed sign Informed consent/assent . Patients know hypersensitivity amlodipine . Patients know sinoatrial nodal disease aortic stenosis . Patients know severe myocardial dysfunction , define A LV ejection fraction ≤ 4 SD age even without symptom . Patients know sign symptom heart failure . Patients T2* value &lt; 4 m cardiac MRI . Patients systolic blood pressure ≤ 2 SD age ( systemic hypotension ) time enrolment . Patients previously diagnose significant congenital heart disease acquire heart disease thalassemia ( define earlier ) . Patients known contraindication MRI ( pacemaker , cerebral aneurysm metal clip , etc . ) Patient know history develop tetany use calcium channel blocker Known pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Chelation</keyword>
	<keyword>T2*</keyword>
	<keyword>MRI</keyword>
	<keyword>Myocardial Iron</keyword>
</DOC>